Silence Therapeutics PLC Asset Resilience Ratio

Latest as of June 2026: 0.00%

Silence Therapeutics PLC asset resilience ratio. Silence Therapeutics PLC (SLN) has an Asset Resilience Ratio of 0.00% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Silence Therapeutics PLC to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$106.41 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Silence Therapeutics PLC (2011–2025)

Asset resilience ratio of Silence Therapeutics PLC from 2011 to 2025. This chart shows how Silence Therapeutics PLC's Asset Resilience Ratio has changed over time. Read SLN current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Silence Therapeutics PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Silence Therapeutics PLC balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Silence Therapeutics PLC maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Silence Therapeutics PLC Industry Peers by Asset Resilience Ratio

Compare Silence Therapeutics PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Silence Therapeutics PLC Asset Resilience Ratio by Year (2011–2025)

Silence Therapeutics PLC asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Silence Therapeutics PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	56.17%	$73.84 Million	$131.44 Million	+43.34pp
2024-12-31	12.83%	$20.77 Million	$161.85 Million	--
2023-12-31	0.00%	$0.00	$94.53 Million	--
2022-12-31	15.19%	$16.33 Million	$107.50 Million	--
2021-12-31	0.00%	$0.00	$96.19 Million	--
2020-12-31	11.63%	$10.00 Million	$85.97 Million	-31.78pp
2019-12-31	43.41%	$20.00 Million	$46.08 Million	+30.44pp
2018-12-31	12.97%	$5.04 Million	$38.88 Million	+12.39pp
2017-12-31	0.58%	$319.00K	$55.01 Million	+0.57pp
2016-12-31	0.01%	$3.00K	$55.79 Million	+0.00pp
2015-12-31	0.00%	$2.00K	$61.55 Million	-16.79pp
2014-12-31	16.79%	$5.00 Million	$29.77 Million	-0.27pp
2013-12-31	17.06%	$5.00 Million	$29.30 Million	+17.05pp
2012-12-31	0.01%	$2.00K	$17.07 Million	-0.10pp
2011-12-31	0.11%	$37.51K	$33.44 Million	--

pp = percentage points

About Silence Therapeutics PLC

NASDAQ:SLN USA Biotechnology

Market Cap

$1.23 Billion

Market Cap Rank

#9277 Global

#2631 in USA

Share Price

$19.75

Change (1 day)

-0.25%

52-Week Range

$4.30 - $19.80

All Time High

$28.35